ralom, as you can see a tonne of companies developing TAVR, TMVR & doing trials sadly couldn't see Admedus in the mix - wish they could get more visibility here taken from a journal read by many serious investors, VCs interested in medtech. going take a big cash pile to push this through clinical trials however it is only one of few decisions that been happy that WP has made to get in this space. let's see how it goes, cash levels are concerning and $18m from a not clear written PR piece for vax doesn not seem great imo, as thought were targeting a big strategic for cash injection was it the end of line to get this cash, who really knows the real facts?
[ATTACH] ralom, as you can see a tonne of companies developing...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.035(0.19%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.65 | $75.19K | 4.184K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 414 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |